These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23930744)

  • 1. Economic costs and quality of life in chronic inflammatory neuropathies in southeast England.
    Mahdi-Rogers M; McCrone P; Hughes RA
    Eur J Neurol; 2014; 21(1):34-9. PubMed ID: 23930744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of chronic inflammatory neuropathies in southeast England.
    Mahdi-Rogers M; Hughes RA
    Eur J Neurol; 2014; 21(1):28-33. PubMed ID: 23679015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
    Hughes RA
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany.
    Mengel D; Fraune L; Sommer N; Stettner M; Reese JP; Dams J; Glynn RJ; Balzer-Geldsetzer M; Dodel R; Tackenberg B
    Muscle Nerve; 2018 Nov; 58(5):681-687. PubMed ID: 30073683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy.
    Guptill JT; Bromberg MB; Zhu L; Sharma BK; Thompson AR; Krueger A; Sanders DB
    Muscle Nerve; 2014 Jul; 50(1):47-51. PubMed ID: 24639235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
    Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
    Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
    Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
    J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Afzal S
    J Neurol; 2019 Feb; 266(2):461-467. PubMed ID: 30556098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy.
    Lucke IM; Adrichem ME; Wieske L; van der Kooi AJ; Verhamme C; van Schaik IN; Eftimov F
    J Neurol Sci; 2019 Feb; 397():141-145. PubMed ID: 30623818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies.
    Gallia F; Balducci C; Nobile-Orazio E
    J Peripher Nerv Syst; 2016 Jun; 21(2):82-4. PubMed ID: 26817673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy.
    McCrone P; Chisholm D; Knapp M; Hughes R; Comi G; Dalakas MC; Illa I; Kilindireas C; Nobile-Orazio E; Swan A; Van den Bergh P; Willison HJ;
    Eur J Neurol; 2003 Nov; 10(6):687-94. PubMed ID: 14641514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
    Racosta JM; Sposato LA; Kimpinski K
    Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy].
    Hughes RA
    Rev Neurol (Paris); 2002 Dec; 158(123):32-36. PubMed ID: 12690331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis.
    Le Masson G; Solé G; Desnuelle C; Delmont E; Gauthier-Darnis M; Puget S; Durand-Zaleski I
    Brain Behav; 2018 Feb; 8(2):e00923. PubMed ID: 29484273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic inflammatory demyelinating polyneuropathy.
    Comi G; Roveri L
    Ital J Neurol Sci; 1998 Oct; 19(5):261-9. PubMed ID: 10933445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in France: are daily practices in accordance with guidelines?
    Rosier C; Graveline N; Lacour A; Antoine JC; Camdessanché JP
    Eur J Neurol; 2019 Apr; 26(4):575-580. PubMed ID: 30326184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases.
    Sala TP; Crave JC; Duracinsky M; Lepira Bompeka F; Tadmouri A; Chassany O; Cherin P
    Autoimmun Rev; 2018 Sep; 17(9):873-881. PubMed ID: 30005853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytosis is a common immune signature in patients with MMN and CIDP and responds to treatment with IVIg.
    Korporal-Kuhnke M; Haas J; Schwarz A; Jarius S; Wildemann B
    J Neuroimmunol; 2015 Jan; 278():60-8. PubMed ID: 25595253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.